CNS Pharmaceuticals, Inc. Liquidation Value
CNSP
Other
Cash & Equivalents
$7.20M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $7.20M
Total Obligations: -$4.10M
$3.10M
Per share: $4.90
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $7.20M
AR: $0
Total Obligations: -$4.10M
$3.10M
Per share: $4.90
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $7.20M
AR: $0
Inventory: $0
Total Obligations: -$4.10M
$3.10M
Per share: $4.90
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $3.10M | $4.90 |
| Liquid Liquidation Value | $3.10M | $4.90 |
| Operating Liquidation Value | $3.10M | $4.90 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $7.20M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $4.10M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 632,516 |
Explore all 80 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $7.20M | N/A | N/A | N/A | $4.10M | N/A | N/A | N/A |
| 2025-09-30 | $9.86M | N/A | N/A | N/A | $1.96M | N/A | N/A | N/A |
| 2025-06-30 | $12.13M | N/A | N/A | N/A | $1.38M | N/A | N/A | N/A |
| 2025-03-31 | $13.05M | N/A | N/A | N/A | $2.78M | N/A | N/A | N/A |
| 2024-12-31 | $6.46M | N/A | N/A | N/A | $2.52M | N/A | N/A | N/A |
| 2024-09-30 | $6.97M | N/A | N/A | N/A | $4.06M | N/A | N/A | N/A |
| 2024-06-30 | $1.49M | N/A | N/A | N/A | $6.76M | N/A | N/A | N/A |
| 2024-03-31 | $815,226 | N/A | N/A | N/A | $6.09M | N/A | N/A | N/A |
▼ Community Notes